The Claim
The use of sleeping pills is associated with a 48% higher relative risk of non-alcoholic fatty liver disease in middle-aged adults, independent of age, sex, BMI, metabolic syndrome, and other lifestyle factors.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Middle-aged adults who use sleeping pills have a 48% higher rate of non-alcoholic fatty liver disease compared to those who do not, even after accounting for age, sex, body weight, metabolic health, and lifestyle factors.
See the scientific wording
The use of sleeping pills is associated with a 48% higher relative risk of non-alcoholic fatty liver disease in middle-aged adults, independent of age, sex, BMI, metabolic syndrome, and other lifestyle factors, suggesting a potential link between pharmacological sleep intervention and liver fat accumulation.
Taking sleeping pills alters the body's natural sleep rhythm, which directly interferes with the liver's ability to manage fat storage and breakdown during the night, leading to excess fat building up in liver cells.
What the research says
1 studyThis study found that middle-aged people who take sleeping pills are about 50% more likely to have fatty liver disease, even when accounting for how much they weigh, how they eat, and other health habits — suggesting a possible link between sleep meds and liver fat.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.